Conventional nuclear medicine and hybrid imaging in monitoring the treatment of skeletal malignancy

Abstract

Skeletal malignancy encompasses both primary malignant bone tumours and bone metastases, the latter being more common. In fact, the skeleton represents one of the most common sites of metastases together with the liver and lungs. The common malignancies that metastasise to the bones are breast, prostate and lung cancers. Primary bone malignancies in contrast are rare, and the relatively common ones include osteosarcoma and Ewing sarcoma.